Emergent BioSolutions Inc. (EBS)
Pharmaceutical Preparations · Healthcare · $401M
Intrinsic Value (Consensus)
$22.45
Current Price
$7.75
Margin of Safety
+189.7%
189.7% Below Intrinsic Value
Value: $22
Price: $8
Valuation Model Estimates
Current Price: $7.75
DCF (Discounted Cash Flow)
$47.63
Graham Number
$14.53
Earnings Power Value
$9.03
Relative Value (P/E)
$18.60
Dividend Discount Model
Not applicable
—
Consensus Value
$22.45
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
59
Profitability
18/25
Strength
15/25
Valuation
22/25
Growth
4/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 113%
Declining revenue — top line is shrinking
High free cash flow yield (39.1%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.93
- EPS (Forward)
- $0.98
- Book Value
- $10.09
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 10.1%
- Debt/Equity
- 113%
- Revenue Growth
- -28.8%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance